Cyanotech Corporation (CYAN) financial statements (2022 and earlier)

Company profile

Business Address 73-4460 QUEEN KAAHUMANU HWY
KAILUA KONA, HI 96740
State of Incorp. NV
Fiscal Year End March 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,2983,7672,4178401,3291,407
Cash and cash equivalents2,2983,7672,4178401,3291,407
Receivables4,5262,4362,1541,9822,6642,135
Inventory, net of allowances, customer advances and progress billings8,7248,4159,65311,2749,0347,972
Inventory8,7248,4159,65311,2749,0347,972
Other undisclosed current assets293488504496590722
Total current assets:15,84115,10614,72814,59213,61712,236
Noncurrent Assets
Operating lease, right-of-use asset3,4123,5173,834
Property, plant and equipment11,93612,13613,04214,75215,73416,712
Restricted cash and investments    65 
Other noncurrent assets112120183282291213
Total noncurrent assets:15,46015,77317,05915,03416,09016,925
TOTAL ASSETS:31,30130,87931,78729,62629,70729,161
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,5663,1312,9865,9144,4194,679
Accounts payable2,2752,2872,1374,9223,5273,666
Accrued liabilities1,2918448499928921,013
Deferred revenue83124327
Debt6262,2102,727948655623
Customer advances and deposits 119
Contract with customer, liability626
Other undisclosed current liabilities3823433192,000633611
Total current liabilities:4,6575,8086,3599,4885,7076,032
Noncurrent Liabilities
Long-term debt and lease obligation, including:7,4277,9989,5285,3726,0236,516
Long-term debt, excluding current maturities4,4004,8236,00957103116
Operating lease, liability3,0273,1753,519
Other undisclosed long-term debt and lease obligation   5,3155,9206,400
Liabilities, other than long-term debt203254  157
Deferred tax liabilities, net  157
Other liabilities203254   
Other undisclosed noncurrent liabilities   (143)(130)(151)
Total noncurrent liabilities:7,4478,0309,5825,2295,8936,522
Total liabilities:12,10413,83815,94114,71711,60012,554
Stockholders' equity
Stockholders' equity attributable to parent19,19717,04115,84614,90918,10716,607
Common stock124122120117115114
Additional paid in capital33,54433,26732,99432,44732,05131,577
Accumulated deficit(14,471)(16,348)(17,268)(17,655)(14,059)(15,084)
Total stockholders' equity:19,19717,04115,84614,90918,10716,607
TOTAL LIABILITIES AND EQUITY:31,30130,87931,78729,62629,70729,161

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
Revenues36,92232,34531,89930,20234,11532,042
Revenue, net 32,042
Cost of revenue
(Cost of Goods and Services Sold)
(24,748)(21,228)(19,199)(19,736)(20,744)(19,818)
Gross profit:12,17411,11712,70010,46613,37112,224
Operating expenses(10,706)(11,033)(11,647)(13,463)(11,957)(12,906)
Operating income (loss):1,468841,053(2,997)1,414(682)
Nonoperating expense    (499)(528)
Interest and debt expense1,6071,389(657)(71)(72)(67)
Other undisclosed income from continuing operations before equity method investments, income taxes     67
Income (loss) from continuing operations before equity method investments, income taxes:3,0751,473396(3,068)843(1,210)
Other undisclosed income (loss) from continuing operations before income taxes(550)(550) (511)72 
Income (loss) from continuing operations before income taxes:2,525923396(3,579)915(1,210)
Income tax expense (benefit)5(3)(9)(17)110(5)
Net income (loss) available to common stockholders, diluted:2,530920387(3,596)1,025(1,215)

Comprehensive Income ($ in thousands)

12/31/2021
TTM
3/31/2021
3/31/2020
3/31/2019
3/31/2018
3/31/2017
Net income (loss):2,530920387(3,596)1,025(1,215)
Comprehensive income (loss), net of tax, attributable to parent:2,530920387(3,596)1,025(1,215)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: